Clinical Trials on Progesteron

Total 159 results

Thomas Jefferson University

Completed

Pharmacokinetics of Progesterone in Pregnancy (PK-PiP)

Progesterone

United States
Universitair Ziekenhuis Brussel

Completed

Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. (PROFETA-5)

Embryo Implantation | Cryopreservation | Progesteron

Belgium
Bezmialem Vakif University

Completed

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

Progesterone

Turkey
ART Fertility Clinics LLC
Merck Serono International SA

Completed

Step Down FSH Approach and Late Follicular Phase in Progesterone Level (FSH)

Progesterone Resistance

United Arab Emirates
ART Fertility Clinics LLC

Completed

Variation of Progesterone in IVF Cycles

Progesterone Resistance

United Arab Emirates
Universitair Ziekenhuis Brussel

Completed

Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone (PROFETA-3)

Progesterone Supplementation

Belgium
Cairo University

Completed

Effect of Intramuscular Progesterone Supplementation on Clinical and Ongoing Pregnancy Rates in Patients With Low Serum Progesterone Levels on the Day of Embryo Transfer in Artificial Frozen Cycles

Frozen Embryo Transfer | Progesterone Supplementation | Serum Progesterone Levels | Clinical Pregnancy Rates | Ongoing Pregnancy Rates

Egypt
Hacettepe University
Anatolia IVF and Women's Health Center

Completed

The Effect of Luteal Blood Progesterone Levels on Ongoing Pregnancy Rates

Luteal Phase Progesterone Levels

Brazil, Denmark, Turkey
Tanta University

Completed

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

Progesterone | Contraceptive Methods

Egypt
Antalya IVF

Terminated

Comparison of Day 19 and Day 20 Artificial FET

Progesterone Induced Endometrial Receptivity

Turkey
University Hospital, Ghent

Recruiting

The Predictive Value of Progesterone (PFRET)

Progesterone Treshold in Artificial Embryo Transfer Cycles

Belgium
Universita di Verona

Completed

Patient's Preferences About Subcutaneous or Vaginal Progesterone Administration for Luteal Phase Support (PROPER-1)

In Vitro Fertilization | Progesterone | Luteal Phase Support

Italy
Mansoura Integrated Fertility Center

Completed

Effect of Timing Progesterone Luteal Support on Embryo Transfer

Embryo Transfer | Progesterone Luteal Support in ICSI
Sezcan Mumusoglu

Completed

The Effect of Progesterone Levels on Pregnancy

Relationship of Progesterone Levels and Pregnancy

Turkey
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Serum Progesterone Level in HRT-FET：a RCT

Progesterone,Hormone Replacement Thawed Embryo Transfer Cycles
Bezmialem Vakif University

Completed

Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle

Infertility | IVF | Progesterone

Turkey
Institut Universitari Dexeus

Completed

Progesterone Variation on the Final Day of Oocyte Maturation.

Circadian Rhythm | Controlled Ovarian Stimulation | Oocyte Donors | Progesterone Variation on Trigger Day

Spain
New Valley University

Completed

Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments

Progesterone Primed Endometrial Protocol | Gonadotropin Releasing Hormone Antagonist Protocol | Assisted Reproductive Treatments

Egypt
University of Alabama at Birmingham

Completed

Hormonal Effects on Pain Perception (HEPP)

Pregnancy | Progesterone Levels | Pregnancy Associated Analgesia

United States
National and Kapodistrian University of Athens
Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa... and other collaborators

Not yet recruiting

Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme

Premature Luteinisation | Progesterone Elevation
Peking Union Medical College Hospital

Unknown

Clinical Study on Endometrial Receptivity

Endometrial Receptivity;RNA; Progesterone

China
Regionshospitalet Viborg, Skive

Completed

The Luteal Phase After GnRHa Trigger - a Proof of Concept Study

Infertility | Progesterone Levels

Denmark
National Cancer Institute (NCI)

Active, not recruiting

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7

United States
University Hospital Inselspital, Berne

Terminated

Progesterone and Resting Energy Expenditure (P4&REE)

Menopause | Weight Gain | Progesterone

Switzerland
Institut Universitari Dexeus

Completed

Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer

Infertility | Pregnancy | Progesterone | Fertilization in Vitro
Ferring Pharmaceuticals

Completed

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures (SARA)

Progesterone Supplementation in Women Undergoing ART

United States
Bezmialem Vakif University

Recruiting

The Importance of Embryo Transfer Day Progesterone Value in Natural Cycle Frozen Embryo Transfers and the Evaluation of the Effect of Rescue Therapy on Pregnancy Outcomes in Patients With Low Progesterone Levels

Infertility | IVF | Progesterone

Turkey
National Cancer Institute (NCI)

Terminated

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive

United States
City of Hope Medical Center
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Completed

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

Stage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaborators

Terminated

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

Stage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma

United States
Istituto Clinico Humanitas

Completed

Debate on Progesterone Elevation on the Day of Triggering (PE)

Progesterone | Embryo Transfer | ART | Female Infertility

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) (ARTT)

Estrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative Neoplasm

Italy
National Cancer Institute (NCI)

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

United States
Infertility Treatment Center Dortmund
Weill Medical College of Cornell University

Completed

Gene-polymorphisms Relating to Human Subfertility

IVF | Subfertility | Estradiol Receptor Polymorphism | Progesterone Receptor Polymorphism

Germany
University of Washington
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...

United States
Institut Universitari Dexeus
Fundación Santiago Dexeus Font; Dexeus Clinic Woman

Completed

Effect of Intervention on Progesterone Levels Before Euploid Embryo Transfer in Pregnancy Outcomes.

Infertility | Frozen Embryo Transfer | Pregnancy Outcome | Progesterone | Euploid Embryo Transfer | Artificial Cycle | Ongoing Pregnancy

Spain
Assiut University

Unknown

Does Premature Luteinization Matter?

Premature Progesterone Rise

Egypt
National Cancer Institute (NCI)

Completed

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7

United States, Puerto Rico
Tanta University

Completed

Progesterone Supplementation in Threatened Abortion (Prothreat)

Threatened Abortion | Progesterone Resistance

Egypt
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Terminated

Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502

Breast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor Negative

United States, Guam
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Inflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

United States
Memorial Sisli Hospital, Istanbul

Unknown

Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles

Drug Effect | Infertility, Female | Dydrogesterone | Infertility, Male | Reproductive Techniques, Assisted | Progesterone | Embryo Transfer | Fertilization in Vitro

Turkey
AC Camargo Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Completed

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)

Neuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor

United States, Brazil
National Cancer Institute (NCI)

Terminated

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive and other conditions

United States
Fengxi Su

Unknown

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Breast Cancer Patients in Premenopausal | Estrogen and/or Progesterone Receptor Positive

China
CRG UZ Brussel
KU Leuven; Abbott; Universitätsklinikum Hamburg-Eppendorf

Completed

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

Infertility | Infertility, Female | Dydrogesterone | Genital Diseases, Female | Progesterone | Hormones | Physiological Effects of Drugs | Genital Diseases, Male | Hormones, Hormone Substitutes, and Hormone Antagonists | Progestins

Belgium
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

Invasive Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive

United States
Kayseri Education and Research Hospital

Completed

Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.

Progesterone Induced Blocking Factor in Endometrial Cancer
Virginia Commonwealth University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Active, not recruiting

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | HER2/Neu Negative | Progesterone Receptor Negative | Estrogen Receptor-positive Breast Cancer | Breast Adenocarcinoma | Progesterone Receptor Positive... and other conditions

United States
University Hospital, Tours
Institut Cancerologie de l'Ouest

Terminated

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer (DHALYA)

Metastatic Breast Cancer | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor | HER-2 Negative Tumor

France

Clinical Trials on Progesteron

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations